-
Lecturer/Senior Lecturer in Exercise Physiology and Sport Science School of Science and Technology Continuing, full-time $104,596 to $123,964 per annum (Level B) $127,836 to $147,207 per annum
-
School of Human Movement and Nutrition Sciences Join a university ranked in the world’s top 50 Full time, continuing Teaching Focused opportunity Genuine career progression opportunities via our
-
university-based research centre, dedicated to the rigorous analysis of American foreign policy, emerging technology, economics, politics and culture. The Centre is a national resource that builds Australia’s
-
Lecturer/Senior Lecturer in Exercise and Sport Science (Biomechanics/Musculoskeletal Rehabilitation)
Lecturer / Senior Lecturer in Exercise and Sport Science (Biomechanics and/or Musculoskeletal Rehabilitation) School of Science and Technology - SABL Continuing, full-time $104,596 to $123,964 per
-
The Opportunity The University of Newcastle is seeking to appoint a Professor to lead the growth and development of its ESSA accredited undergraduate and postgraduate Exercise and Sport Science and
-
required to provide evidence of immunisation against certain vaccine preventable diseases. Exercise and Sports Science Australia accreditation: It is a requirement of this position that the incumbent holds
-
of American foreign policy, emerging technology, economics, politics and culture. The Centre is a national resource, that builds Australia’s awareness of the dynamics shaping America and their implications
-
Sciences), by [email protected] . Our Commitment to Protecting Country: Victoria University honours its deep diversity as a foundation for collaboration and social progress. We will demonstrate
-
$78,854 TO $87,624 PA FULL TIME, FIXED TERM CONTRACT Overview The Exercise Medicine Research Institute houses an innovative, multi-disciplinary and productive world leading research team in exercise science
-
leading research team in exercise science dedicated to investigating the extent to which exercise can be employed in chronic disease management, principally cancer, to materially improve patient outcomes